The global vasopressin market was valued at USD 2.4 billion in 2025 and is projected to reach USD 8 billion by 2035, expanding at a CAGR of 14.4% during the forecast period. This growth is driven by rising prevalence of conditions such as sepsis, diabetes insipidus, and gastrointestinal bleeding, as well as increased adoption of critical care treatments and hospital-based intervention... https://www.researchnester.com/reports/vasopressin-market/8158